Ligand Pharmaceuticals Inc. (NASDAQ: LGND) hit a 52-week high of $139.79 at the beginning of August. Since then, the stock has been steadily declining and as of Wednesday was trading for less than $109 per share.
The stock is now nearly flat...
$139.79 - August 1 high (all-time-high)
$138.53 - August 1 close (all-time-closing high)
$113.47 - Monday close
$113.25 - Tuesday high
$111.31 - Intraday high as of 12:16 PM
$110.92 - Tuesday close
Shares of Ligand Pharmaceuticals Inc. (NASDAQ: LGND) have gained 6.1 percent over the year, posting a performance similar to that of the Dow Jones Industrial Average. Over the past six months, however, the stock moved up more than 30 percent. The...
Deutsche Bank has downgraded Ligand Pharmaceuticals Inc. (NASDAQ: LGND) to Sell from Hold on valuation.
Despite acknowledging the long-term potential of Ligand's "more than 150 shots-on-goal," the brokerage sees downside in shares over the next...
WASHINGTON (dpa-AFX) - Ligand Pharmaceuticals Inc (LGND) announced a profit
for second quarter that retreated from last year.
The company said its profit declined to $10.81 million, or $0.50 per share.
This was lower than $38.48 million, or...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Ligand Pharmaceuticals (LGND):